PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP
Clinical trial NCT00088231 · COMPLETED
Trial details
- NCT number
- NCT00088231
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
- Primary completion
- 2006-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.